CT and18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma

American Journal of Roentgenology

Volumn 192, Issue 3, 2009, Pages 745-753

  De Jong, Pim A ^a,b   Van Ufford, Henriette M Quarles ^a,b   Baarslag, Henk Jan ^a   De Haas, Marie J ^a   Wittebol, Shulamiet H ^a   Quekel, Lorentz G ^a   De Klerk, John M ^a  

^a MEANDER MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

CT; FDG PET; Lymphoma; Sensitivity; Specificity; Splenic index; Splenic involvement

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ADOLESCENT; AGED; LONGITUDINAL STUDY; METHODOLOGY; MIDDLE AGED; PATIENT SELECTION; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; SPLEEN TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LONGITUDINAL STUDIES; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SPLENIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 63049097468     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.08.1160     Document Type: Article

References (26)

1. Armitage JO. Staging non-Hodgkin lymphoma. CA Cancer J Clin 2005; 55:368-376
2. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31:1860-1861
3. Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 1989; 7:1630-1636
4. Munker R, Stengel A, Stäbler A, Hiller E, Brehm G. Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease: verification by laparotomy in 100 cases. Cancer 1995; 76:1460-1466
5. Castellino RA, Hoppe RT, Blank N, et al. Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkin disease. AJR 1984; 143:37-41
6. Strijk SP, Wagener DJ, Bogman MJ, de Pauw BE, Wobbes T. The spleen in Hodgkin disease: diagnostic value of CT. Radiology 1985; 154:753-757
7. Even-Sapir E, Lievshitz G, Perry C, Herishanu Y, Lerman H, Metser U. Fluorine-18 fluorodeoxyglu- cose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease. Radiol Clin North Am 2007; 45:697-709
8. Rueffer U, Sieber M, Stemberg M, et al.; German Hodgkin's Lymphoma Study Group (GHSG). Spleen involvement in Hodgkin's lymphoma: assessment and risk profile. Ann Hematol 2003; 82:390-396
9. Strijk SP, Boetes C, Bogman MJ, de Pauw BE, Wobbes T. The spleen in non-Hodgkin lymphoma: diagnostic value of computed tomography. Acta Radiol 1987; 28:139-144
10. Sandrasegaran K, Robinson PJ, and Selby P. Staging of lymphoma in adults. Clin Rad 1994; 49: 149-161
11. Moog F, Bangerter M, Diederichs CG, et al. Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology 1998; 206:475-481
12. Partridge S, Timothy A, O'Doherty MJ, Hain SF, Rankin S, Mikhaeel G. 2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution. Ann Oncol 2000; 11:1273-1279
13. Daskalogiannaki M, Prassopoulos P, Katrinakis G, Tritou I, Eliopoulos G, Gourtsoyiannis N. Splenic involvement in lymphomas: evaluation on serial CT examinations. Acta Radiol 2001; 42: 326-332
14. Rini JN, Leonidas JC, Tomas MB, Palestro CJ. 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J NucI Med 2003; 44:1072-1074
15. Rini JN, Manalili EY, Hoffman MA, et al. F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Clin NucI Med 2002; 27:572-577
16. Lackner K, Brecht G, Janson R, Scherholz K, Lut- zeler A, Thurn P. Wertigkeit der Computertomog- raphie bei der Stadieneinteilung primarer Lymph- knotenneoplasien. Rofo 1980; 132:21-30
17. Prassopoulos P, Daskalogiannaki M, Raissaki M, Hatjidakis A, Gourtsoyiannis N. Determination of normal splenic volume on computed tomogra phy in relation to age, gender and body habitus. Eur Radiol 1997; 7:246-248
18. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25:571-578
19. Sugawara Y, Zasadny KR, Kison PV, Baker LH, Wahl RL. Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results. J Nucl Med 1999; 40:1456-1462
20. Cheson BD, Pfistner B, Juweid ME, et al.; International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25:579-586
21. Goerg C, Schwerk WB, Goerg K, et al. Sono-graphic patterns of the affected spleen in malignant lymphoma. J Clin Ultrasound 1990; 18:569-574
22. Dachman AH. Lymphoma and primary splenic neoplasms. In: Dachman AH, Friedman A, eds. Radiology of the spleen. St. Louis, MO: Mosby-Year Book, 1993:94-103
23. Hernandez-Maraver D, Hernandez-Navarro F, Gomez-Leon N, et al. Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma. Br J Haematol 2006; 135:293-302
24. Bhatia K, Sahdev A, Reznek RH. Lymphoma of the spleen. Semin Ultrasound CT MR 2007; 28: 12-20
25. Geus-Oei LF, Oyen WJ. Predictive and prognostic value of FDG-PET. Cancer Imaging 2008; 8:70-80
26. Ford CD, Gabor F, Morgan R, Dabbas B. False- positive restaging PET scans involving the spleen in two patients with aggressive non-Hodgkin lymphoma. Clin Nucl Med 2006; 31:391-393